Interaction of agonist peptide [3H]Tyr-D-Ala-Phe-Phe-NH2 with μ- opioid receptor in rat brain and CHO-μ/1 cell line

Peptides

Volumn 19, Issue 6, 1998, Pages 1091-1098

  Spetea, Mariana ^a   Ötvös, Ferenc ^a   Tóth, Géza ^a   Nguyen, Thi M D ^b   Schiller, Peter W ^b   Vogel, Zvi ^c   Borsodi, Anna ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Opioid agonist peptides; 3H TAPP; CHO l cell line; Opioid receptors; Radioligand binding; Rat brain

Indexed keywords

ENDORPHIN DERIVATIVE; MU OPIATE RECEPTOR; TRITIUM; TYROSYL DEXTRO ALANYLPHENYLALANYLPHENYLALANINE AMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHO CELL; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

ANIMALS; BRAIN; CHO CELLS; CRICETINAE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; GUANYLYL IMIDODIPHOSPHATE; LIGANDS; OLIGOPEPTIDES; RATS; RECEPTORS, OPIOID, MU; TRITIUM;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; TRITIUM;

EID: 0344269350     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00023-0     Document Type: Article

References (42)

1. 3H)-dermorphin in rat brain. Int. J. Pept. Protein Res. 32:506-511; 1988.
2. Avidor-Reiss, T.; Bayewitch, M.; Levy, R.; Matus-Leibovitch, N.; Nevo, I.; Vogel, Z. Adenylylcyclase supersensitization in μ-opioid receptor transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270:29732-29738; 1995.
3. 3H]-PL17. Mol. Pharmacol. 31:326-333; 1987.
4. Borsodi, A.; Tóth, G. Characterization of opioid receptor types and subtypes with new ligands. Ann. N.Y. Acad. Sci. 757: 339-352; 1995.
5. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254; 1986.
6. Bunzow, J. R.; Zhang, G.; Bouvier, C.; Saez, C.; Ronnekleiv, O. K.; Kelly, M. J.; Grandy, D. K. Characterization and distribution of a cloned rat μ-opioid receptor. J. Neurochem. 64:14-24; 1995.
7. Chang, K.J.; Wei, E. T.; Killian, A.; Chang, J.-K. Potent morphiceptin analogs: structure-activity relationships and morphine-like activities. J. Pharmacol. Exp. Ther. 227:403-408; 1983.
8. Childers, S. R. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991-2003; 1991.
9. 6(O-tert-butyl): two new enkephalin analogs with both a good selectivity and a high affinity toward δ-opioid binding sites. J. Biol. Chem. 263:4124-4130; 1988.
10. Fukuda, K.; Kato, S.; Mori, K.; Nishi, M.; Takeshima, H. Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. FEBS Lett. 327:311-314; 1993.
11. Gacel, G.; Zajac, J. M.; Delay-Goyet, P.; Dage, V.; Roques, B. P. Investigation of the structural parameters involved in the μ and δ opioid receptor discrimination of linear enkephalin-related peptides. J. Med. Chem. 31:374-383; 1988.
12. 61-64 possessing selective agonist activity at μ-opiate receptors. Eur. J. Pharmacol. 70:531-540; 1981.
13. Kieffer, B. L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol. Neurobiol. 15:615-635; 1995.
14. Knapp, R. J.; Malatynska, E.; Collins, N.; Fang, L.; Wang, J. Y.; Hruby, V. J.; Roeske, W. R.; Yamamura, H. I. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9:516-525; 1995.
15. Kong, H.; Raynor, K.; Yasuda, K.; Moe, S. T.; Portoghese, P. S.; Bell, G. I.; Reisine, T. A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268:23055-23058; 1993.
16. 3H] naloxone binding sites by C-6 derivatives of morphinan-6-ones. Life Sci. 48:439-451; 1991.
17. Mignogna, G.; Severini, C.; Simmaca, M.; Negri, L.; Falconieri Erspamer, G.; Kreil, G.; Barra, D. Identification and characterization of two dermorphins from skin extracts of the Amazonian frog Phyllomedusa bicolor. FEBS Lett. 302:151-154; 1992.
18. Misicka, A.; Lipkowski, A. W.; Slaninova, J.; Davis, P.; Yamamura, H. I.; Porreca, F.; Hruby, V. J. The synthesis and opioid receptor binding affinities of analogs of dermorphin and its N-terminal tetrapeptide fragment with dibasic acids in position 2. Life. Sci. 18:1633-1640; 1995.
19. Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Gee, K. W.; Yamamura, H. I.; Galligan, J. J.; Burks, T. F. Bis-penicillamin enkephalins possess highly improved specificity toward d opioid receptors. Proc. Natl. Acad. Sci. USA. 80:5871-5874; 1983.
20. Munson, P. J.; Rodbard. D. LIGAND. A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239; 1980.
21. Negri, L.; Falconieri Erspamer, G.; Severini, C.; Potenza, R. L.; Melchiori, P.; Erspamer, V. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two μ opioid subtypes that modulate antinociceptine and catalepsy in the rat. Proc. Natl. Acad. Sci. USA. 89:7203-7207; 1992.
22. Pasternak, G. W. Pharmacological mechanisms of opioid analgesia. Clin. Neuropharmacol. 16:1-18; 1993.
23. Pasternak, G. W.; Wood, P. J. Multiple mu receptor. Life Sci. 38:1889-1898; 1986.
24. Pert, C. B.; Snyder, S. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 10:808-879; 1974.
25. Piros, E. T.; Hales, T. G.; Evans, C. J. Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem. Res. 21:1277-1285; 1996.
26. Portoghese, P. S.; Sultana, M.; Nagase, H.; Takemori, A. E. Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists. J. Med. Chem. 31:281-282; 1988.
27. Raynor, K.; Kong, H.; Chen, Y.; Yasuda, K.; Yu, L.; Bell, G. I.; Reisine, T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45: 330-334; 1994.
28. 2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for the dermorphin related opioid peptides. Proc. Natl. Acad. Sci. USA. 87:4836-4839; 1990.
29. 2]Deltrophin II analogs with high affinity and selectivity for delta-opioid receptor. Biochem. Biophys. Res. Commun. 180:822-827; 1991.
30. Schiller, P. W. Development of receptor-specific opioid peptide analogues. In: Ellis, G. P.; West, G. B.; eds. Progress in Medicinal Chemistry, Vol. 28. Amsterdam: Elsevier Science Publishers; 1991:301-340.
31. Schiller, P. W.; Nguyen, T. M.-D.; Chung, N. N.; Lemieux, C. Dermorphin analogues caring an increased positive charge in their "message" domain display extremely high μ opioid receptor selectivity. J. Med. Chem. 32:698-703; 1989.
32. Schiller, P. W.; Weltrowska, G.; Nguyen T. M.-D.; Wilkens, B. C.; Chung, N. N.; Lemieux, C. TIPP[ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 36:182-3187; 1993.
33. Schmidhammer, H.; Burkard, W. P.; Eggstein-Aeppli, L.; Smith, C. F. C. Synthesis and biological evaluation of 14-alkoxymorphinans. 2(-)-N-cyclopropylmethyl-4,14-dimethoxymorphinan-6-one, a selective μ opioid receptor antagonist. J. Med. Chem. 32:418-421; 1989.
34. Simon, J.; Benyhe, S.; Abutidze, K.; Borsodi, A.; Szücs, M.; Wollemann, M. Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS. J. Neurochem. 46:695-701; 1986.
35. Takemori, A. E.; Portoghese, P. S. Selective naltrexone-derived opioid receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32:239-269; 1992.
36. Talmont, F.; Sidobre, S.; Demange, P.; Milon, A; Emorine, L. Expression and pharmacological characterization of the human μ-opioid receptor in the methylotropic yeast Pichia pastoris. FEBS Lett. 394:268-272; 1996.
37. Tóth, G.; Lovas, S.; Ötvös F. Tritium labeling of neuropeptides. In: Irvine, G. B.; Williams, C. H.; eds. Methods in molecular biology, Neuropeptides protocols. Totowa: Humana Press; 1997:19-230.
38. 3H-Tyr-D-Ala-Gly-N(Me)Phe-chlormethyl ketone-an opioid affinity label. Neuropeptides. 12:135-139; 1988.
39. Wang, J. B.; Imai, Y.; Eppler, C. M.; Gregor, P.; Spivak, C. E.; Uhl, G. R. μ Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA. 90:10230-10234; 1993.
40. Weiland, G. A.; Molinoff, P. B. Quantitative analysis of drug receptor interactions: determination of kinetic and equilibrium properties. Life Sci. 29:313-330; 1981.
41. Zadina, J. E.; Hackler, L.; Ge, L.-J.; Kastin, A. J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature (London). 386:499-502; 1997.
42. Zaki, P. A.; Bilski, E. J.; Vanderah, T. W.; Lai, J.; Evans, C. J.; Porreca, F. Opioid receptor types and subtypes: the δ receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36:379-401; 1996.